{"id":"W4317105117","doi":"10.1093/ehjcvp/pvad006","title":"Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial","year":2023,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"Janssen Pharmaceuticals; Abbott Vascular; CytoSorbents Europe; MicroPort; Idorsia Pharmaceuticals; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; PharmaMar; Eisai; Sanofi; Abiomed; Amarin Pharma; Novo Nordisk; AtriCure; Daiichi-Sankyo; Medicines Company; AstraZeneca; Amarin Corporation; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Daiichi Sankyo Europe; Gilead Sciences; Amgen; Pfizer; Boston Scientific Corporation; National Science Foundation","keywords":"Ticagrelor; Medicine; Aspirin; Percutaneous coronary intervention; Internal medicine; Hazard ratio; Conventional PCI; Myocardial infarction; Clinical endpoint; Placebo; Stroke (engine); Cardiology; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002915345,0.001460205,0.005306856,0.0006791076,0.0003437582,0.001704061,0.0007353777,0.001476851,0.002810354],"category_scores_gemma":[0.004223536,0.0004602583,0.009571388,0.001086654,0.0003625351,0.0006099319,0.0006567101,0.001672254,0.0003092268],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004426175,"about_ca_system_score_gemma":0.0007442984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001466297,"about_ca_topic_score_gemma":0.003722888,"domain_scores_codex":[0.9978089,0.001077815,0.0003488432,0.0003295661,0.000218349,0.0002164666],"domain_scores_gemma":[0.9983511,0.0006191771,0.0004254594,0.0002981628,0.000105959,0.0002001889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6949911,0.0007992499,0.08890602,0.005529844,0.1590533,0.001067054,0.000245253,0.001077374,0.004407235,0.0004692171,0.004066582,0.03938772],"study_design_scores_gemma":[0.3654033,0.02640692,0.2985289,0.001123075,0.2913733,0.0014918,0.0006332944,0.005388634,0.001402636,0.002831189,0.005145366,0.0002716743],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9469572,0.04540988,0.0008856146,0.0009906072,0.0009090306,0.0006780145,0.002054383,0.00005309101,0.002062084],"genre_scores_gemma":[0.992555,0.003396218,0.0004416408,0.0006237758,0.0006155116,0.0004084562,0.001311596,0.00002012499,0.0006276718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005306856,"threshold_uncertainty_score":0.01541805,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01962897758834716,"score_gpt":0.2786518573281694,"score_spread":0.2590228797398222,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}